Kojin Therapeutics

1 follower


Kojin is harnessing groundbreaking discoveries in cell state and ferroptosis biology to create novel therapies and cures for diseases traditionally considered intractable.

Industries

Headquarters

Stage

Employees

Links

Org chart

Harvey Berger
Chairman, Chief Executive Officer & President
Gang Xing
Head, Biomarker Development
Lakshmi Amaravadi
Head, Preclinical Development & Translational Medicine
Nagesh Mahanthappa
Independent Director
Mathias Wawer
Director, Computational Biology